Your search terms:

meta product liability

Search results sorted by date

Litigation Piles Up as Google Confronts Social Media MDL and Potential Breakup

In a stunning opinion issued last week, Judge Amit Mehta of the District of Columbia District Court found that search engine giant Google is...

Analytics Reveal Inside Look at Bicycle Recall Lawsuits

On September 21, 2023 Shimano, the world’s largest manufacturer of bicycle components, announced a voluntary product recall of their top-tier eleven-speed cranksets. On a...

Facebook’s Messy Crypto Aftermath

FOIAengine: New York AG Targets Diem Association, aka Libra It was the end of January 2022, and Stuart Levey was celebrating.  As the Treasury Department’s former...

Litigation Jungle: Amazon Faced 13,000 Actions in Last Six Years

With net sales of over $514 billion in 2022, Amazon is among America's and the world's highest earning companies. Its business is diverse—from pharmacy...

Meta Settles Consumer Privacy MDL for Record-Setting $725M

Late last week, the plaintiffs prosecuting multidistrict litigation against Facebook styled In re Facebook Inc. Consumer Privacy User Profile Litigation moved to settle the...

MDL Court Appoints Lead Counsel in Youth Consumers’ Social Media Product Liability Litigation

On Thursday, the Northern District of California court overseeing the class action against social media platform operators Meta Platforms, TikTok, Snap, and YouTube issued...

NDCA Court Sets up Procedural Parameters of Social Media Addiction/Personal Injury MDL

Within a week of the Judicial Panel on Multidistrict Litigation’s (JPML) consolidation and transfer of more than two dozen actions against social media platform...

JPML: Social Media Product Liability Suits Against Meta, Snap, TikTok and YouTube to Proceed in N.D. Cal.

An order issued by the Judicial Panel on Multidistrict Litigation (JPML) late last week consolidated more than two dozen actions pending across the country...
- Advertisement -spot_img

Latest news

Latham and Covington Advise on Novartis’s Acquisition of Regulus

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800...

The Crook, the Tycoon, the Short Seller, and Trump

FOIAengine Tracks the High Cost of Getting Even, and the Rewards Until six weeks ago, Jason Galanis was Inmate 80739-198...

Pharma Knock-Offs, a Secret Email Address, and a Smooth Spin of the Revolving Door

The Latest Requests Logged in FOIAengine  Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s...